Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...

Stifel Nicolaus analyst Cole McGill maintained a Buy rating on ioneer Limited (GSCCF – Research Report) today and set a price target of A$0.40.

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

Stifel analysts, led by Brian Chin, reaffirmed their Hold rating on shares of FormFactor (NASDAQ:FORM), with a steady price ...

Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...

Local leaders descended upon the Stifel Fine Arts Center this evening for the Leadership Wheeling Kickoff Reception for 2025. Leadership Wheeling is a program ...

David Swartz, a senior equity analyst at Morningstar Research Services, told Retail Dive that VF has been “cutting costs and ...

Vail Resorts issued its annual early season update to investors on Thursday, reporting that season-to-date total skier visits ...

Hennion & Walsh Asset Management Inc. lowered its position in Electronic Arts Inc. (NASDAQ:EA – Free Report) by 4.9% in the ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...